IIM
RGNX icon

Ipswich Investment Management’s Regenxbio RGNX Stock Holding History

Ipswich Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-29,132
Closed -$1.67M – 179
2019
Q1 		$1.67M Sell
29,132
-570
-2% -$28.2K 0.55% 55
2018
Q4 		$1.25M Sell
29,702
-230
-0.8% -$13.5K 0.46% 60
2018
Q3 		$2.26M Sell
29,932
-1,339
-4% -$96.5K 0.76% 43
2018
Q2 		$2.24M Buy
31,271
+9,386
+43% +$448K 1.03% 38
2018
Q1 		$653K Buy
21,885
+5
+0% +$146 0.28% 86
2017
Q4 		$728K Buy
+21,880
New +$659K 0.31% 80

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ipswich Investment Management's RGNX Position: Q2 2019 in Review

Ipswich Investment Management sold out of Regenxbio (RGNX) in Q2 2019, closing a stake of 29,132 shares — an estimated $1.67M sold.

Ipswich Investment Management first reported a position in RGNX in Q4 2017 and held it in 6 quarters. The position peaked at $2.26M in Q3 2018. 186 funds tracked by Wall St. Rank hold RGNX as of Q2 2019.

  • Ipswich Investment Management reported no remaining Regenxbio position as of Q2 2019 after selling out during the quarter.
  • Ipswich Investment Management sold 29,132 Regenxbio shares in Q2 2019, an estimated $1.67M.
  • Ipswich Investment Management first reported a position in Regenxbio in Q4 2017 and held it in 6 quarters.
  • Ipswich Investment Management's Regenxbio position peaked at $2.26M in Q3 2018.
  • 186 funds tracked by Wall St. Rank held Regenxbio as of Q2 2019.

Based on Ipswich Investment Management's 13F filing for Q2 2019, filed 11 Jul 2019.